Answers are grounded in this paper and cite their sources.
Our study found that peripheral venous catheter use for vasopressor administration in circulatory shock was associated with a low extravasation rate (1.2%), with all events occurring after more than five days, indicating it might be a safe alternative to CVC for short-term use in resource-limited settings. Findings support cautious prolonged use and consideration of central access when therapy exceeds a few days. This calls for randomized controlled trials to compare the safety and efficacy of vasopressor administration by PVC versus CVC.
No takes yet. Share an insight, caveat, or question.
Petros et al. (2025) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: